Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Huge Biotech M&A Premiums Narrow Perception Gap
![](https://talkmarkets.com/user_content/contacts/thumb_F5AF80B5-2BC4-4F5E-A81F-3E73F5969A0E.jpeg?app=297813)
Article By:
Lipper Alpha Insight
Wednesday, December 4, 2019 6:27 AM EDT
The premiums needed to seal biotechnology acquisitions have always been high, but they’ve reached the stratosphere this year
3 Promising Gene Therapy Stocks
![](https://talkmarkets.com/user_content/contacts/thumb_CBD21286-3D35-4D9F-81E1-75C1B44F5A40.jpeg?app=232227)
Article By:
Tarun Chandra, CFA
Saturday, May 25, 2019 9:45 PM EDT
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.
In this article: BOLD, VYGR, QURE Also: SRPT, PTCT, BLUE, ONCE, EDIT, NTLA, CRSP, RGNX, SLDB, FIXX, MGTX, NVS, RHHBY, GOOG, ACAD, ARNA, ARRY, CBPO, PCRX, AMRN, SAGE, MRNA, GWPH, ASND, RARX, BHVN, MRTX, DNLI, CHRS, MDCO, ARWR, ZIOP, TGTX, PTLA, GBT, AXSM
3 Gene Therapy Stocks Investors Can Bet On In Rest Of 2018
![](https://talkmarkets.com/user_content/contacts/thumb_974E840B-81A9-437A-8FC5-0A85B46C2A57.jpeg?app=196659)
Article By:
Zacks Investment Research
Friday, July 13, 2018 3:05 AM EDT
Innovation holds the key in the pharma/biotech sector and most companies have been diverting their resources to develop gene therapy candidates in their goal of finding a cure for difficult and incurable diseases.